IGE-MEDIATED HYPERSENSITIVITY

Clinical trials for IGE-MEDIATED HYPERSENSITIVITY explained in plain language.

Never miss a new study

Get alerted when new IGE-MEDIATED HYPERSENSITIVITY trials appear

Sign up with your email to follow new studies for IGE-MEDIATED HYPERSENSITIVITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New drug targets root cause of severe allergies

Disease control Not yet recruiting

This is an early-stage study testing a new drug called cizutamig in people with severe allergies caused by high IgE levels. The main goal is to see if the drug safely lowers IgE in the blood and how the body handles it. It will involve about 20 adults with conditions like severe …

Matched conditions: IGE-MEDIATED HYPERSENSITIVITY

Phase: PHASE1 • Sponsor: Candid Therapeutics • Aim: Disease control

Last updated Mar 18, 2026 14:55 UTC

IGE-MEDIATED HYPERSENSITIVITY

Get alerted when new IGE-MEDIATED HYPERSENSITIVITY trials appear

New drug targets root cause of severe allergies